Key result
Paliperidone administration was associated with the possible development of neuroleptic malignant syndrome.
Paliperidone administration may be associated with Neuroleptic Malignant Syndrome.
Vigilance for NMS warranted with paliperidone; leaves open causality and incidence in larger cohorts.
No takes yet. Share an insight, caveat, or question.
Mantas et al. (2010) studied this question. Paliperidone administration was associated with the possible development of neuroleptic malignant syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: